AVIR Stock-Based Compensation
Atea Pharmaceuticals Inc · Stock-Based Compensation
AVIR Stock-Based Compensation
Latest reported$16.21Mperiod ending
AVIR Stock-Based Comp ($414.00K → $16.21M)
Annual stock-based compensation
High-resolution chart · PNG
AVIR stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 20,720,000 | |
| 51,767,000 | |
| 49,428,000 | |
| 46,718,000 | |
| 39,621,000 | |
| 7,457,000 | |
| 624,000 | |
| 414,000 |